Share

June 01, 2018; 8 (3) Commentary

Practice Current: When do you order ancillary tests to determine brain death?

Nathaniel M. Robbins, James L. Bernat
First published May 23, 2018, DOI: https://doi.org/10.1212/CPJ.0000000000000473
Full PDF
Citation
Permissions

Comment

Downloads
151

Share

Article Information

vol. 8 no. 3 266-274
DOI: 
https://doi.org/10.1212/CPJ.0000000000000473
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
2163-0402
Online ISSN: 
2163-0933
History: 
  • Received February 7, 2018
  • Accepted April 11, 2018
  • First Published May 23, 2018.

Article Versions

Copyright & Usage: 
© 2018 American Academy of Neurology

Author Information

    1. Nathaniel M. Robbins, MD and
    2. James L. Bernat, MD
  1. Nathaniel M. Robbins, MD and
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. (1) Peripheral Nerve and Muscle Disease, Oxford University Press, 2016

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other activities:

    1. (1) Clinical trial and travel support from Vertex Pharmaceuticals for their clinic trial of VX-150 for small fiber neuropathy (2) Market Research Honoraria from Compass Inc.

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. Vertex Pharmaceutical (see above)

    Research Support, Government Entities:

    1. 1. Department of State Fulbright Research Scholarship, PI, 2017-2018

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. 1. Hitchcock Foundation 2. Dartmouth Diamond Endowment Fund

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. James L. Bernat, MD
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. Editorial Board: Neurocritical Care: 2002-present (no compensation) Editorial Board: Neurology Today: 2001-2017 (no compensation) Editorial Board: The Physician's Index for Ethics and Medicine: 2011-present (compensation) Editorial Board: Multiple Sclerosis and Related Diseases: 2011-present (no compensation) Editorial Board: Neurology Clinical Practice (no compensation)

    Patents:

    1. NONE

    Publishing Royalties:

    1. Ethical and Legal Issues in Neurology. Elsevier, 2013 Ethical Issues in Neuorology, 3rd ed. Lippincott Williams & Wilkins, 2008. Palliative Care in Neurology. Oxford University Press, 2004.

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NIH Director, Ethics Core of SYNERGY: The Dartmouth Clinical and Translational Science Institute. National Center for Advancing Translational Sciences (NIH NCATS) UL1TR001086. (10% salary provision)

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. Department of Neurology, Geisel School of Medicine at Dartmouth, Hanover, NH.
  1. Correspondence
    Dr. Robbins Nathaniel.M.Robbins{at}dartmouth.edu
View Full Text

Article usage

Article usage: May 2018 to July 2018

AbstractFullPdfSource
May 2018377034Highwire
Jun 201812969399Highwire
Jul 20186384618Highwire

The Nerve!: Rapid online correspondence

Comment

NOTE: All contributors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.cp.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.

  • Stay timely. Submit only on articles published within the last 8 weeks.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • 200 words maximum.
  • 5 references maximum. Reference 1 must be the article on which you are commenting.
  • 5 authors maximum. Exception: replies can include all original authors of the article.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on The Nerve!

Compose comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All contributors, besides the first/corresponding author, must complete a separate The Nerve! Submission Form and provide via email to the editorial office before comments can be posted.

Vertical Tabs

You May Also be Interested in

Back to top

Related Articles

  • No related articles found.

Topics Discussed

Alert Me